Noveome Biotherapeutics
Houman David Hemmati MD PhD serves as the Chief Medical Affairs Officer at Vyluma and is a Co-Founder and Chief Scientific Officer at Levation Pharma, Ltd. Hemmati is also a Co-Founder and Chief Medical Officer at Optigo Biotherapeutics and holds positions as a Member of the Board of Directors at both Noveome Biotherapeutics, Inc. and Trailhead Biosystems Inc. Hemmati earned a Doctor of Medicine degree from the David Geffen School of Medicine at UCLA in 2006 and a PhD from Caltech in 2004.
This person is not in any teams
This person is not in any offices
Noveome Biotherapeutics
Noveome Biotherapeutics, Inc. is a clinical stage company focused on breakthrough therapies for the regenerative repair of inflamed or damaged tissues.